Bolt Biotherapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BOLT Nasdaq 2836 www.boltbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bolt Biotherapeutics, Inc.

Metastatic HER2-Positive Breast Cancer Market Expected to Surge at a CAGR of 8.3% During the Forecast Period (2026–2036) Due to Advancing Targeted Treatments | DelveInsight - Jun 1st, 2026 11:00 am
Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates - May 12th, 2026 3:40 pm
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - May 12th, 2026 2:05 pm
Bolt Metals Corp. Announces Appointment of Chief Financial Officer and Corporate Secretary - Apr 9th, 2026 1:00 am
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates - Mar 12th, 2026 3:45 pm
Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - Mar 12th, 2026 2:51 pm
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - Mar 12th, 2026 2:05 pm
Bolt Biotherapeutics to Participate in Upcoming March Conferences - Feb 24th, 2026 6:00 am
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates - Nov 12th, 2025 3:25 pm
Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot - Nov 12th, 2025 2:21 pm
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 12th, 2025 2:05 pm
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy? - Nov 4th, 2025 8:00 am
Sector Update: Health Care Stocks Retreat Late Afternoon - Oct 2nd, 2025 1:58 pm
Washington Shutdown Continues as US Equity Futures Trade Mixed Ahead of Opening Bell - Oct 2nd, 2025 7:20 am
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 - Oct 1st, 2025 2:05 pm
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates - Aug 14th, 2025 3:25 pm
Bolt Biotherapeutics Inc.: Q2 Earnings Snapshot - Aug 14th, 2025 2:24 pm
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - Aug 14th, 2025 2:05 pm
ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates - Aug 8th, 2025 6:00 am
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates - Aug 7th, 2025 6:10 am